NCT02205801 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 8 months
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Superficial Cervical Block, Active | 0 / 11 | 0 / 11 | 0 / 11 |
| Superficial Cervical Block, Placebo | 0 / 8 | 0 / 8 | 0 / 8 |
| Local Wound Infiltration, Active | 0 / 9 | 0 / 9 | 0 / 9 |
| Local Wound Infiltration, Placebo | 0 / 8 | 0 / 8 | 0 / 8 |
Serious adverse events
Other reported adverse events
Complete source fields
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 11
- description
- After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.25% Marcaine. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 11
- serious Num Affected
- 0
- serious Num At Risk
- 11
- title
- Superficial Cervical Block, Active
- deaths Num Affected
- 0
- deaths Num At Risk
- 8
- description
- After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.9% saline. Superficial Cervical Plexus Block: 0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
- id
- EG001
- other Num Affected
- 0
- other Num At Risk
- 8
- serious Num Affected
- 0
- serious Num At Risk
- 8
- title
- Superficial Cervical Block, Placebo
- deaths Num Affected
- 0
- deaths Num At Risk
- 9
- description
- After induction of general anesthesia the surgeon will perform a local wound infiltration using 0.25% Marcaine. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. Marcaine
- id
- EG002
- other Num Affected
- 0
- other Num At Risk
- 9
- serious Num Affected
- 0
- serious Num At Risk
- 9
- title
- Local Wound Infiltration, Active
- deaths Num Affected
- 0
- deaths Num At Risk
- 8
- description
- After induction of general anesthesia the surgeon will perform local wound infiltration using 0.9% Saline. Local Wound Infiltration: 0.50% Marcaine is injected at the site of incision (10mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy. 0.9% saline
- id
- EG003
- other Num Affected
- 0
- other Num At Risk
- 8
- serious Num Affected
- 0
- serious Num At Risk
- 8
- title
- Local Wound Infiltration, Placebo
- frequency Threshold
- 5
- time Frame
- 8 months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle